Ticker > Company >

Link Pharma Chem share price

Link Pharma Chem Ltd.

BSE: 524748 SECTOR: Pharmaceuticals & Drugs  11.98 K   29   2

35.99
+1.09 (3.12%)
BSE: 29 Oct 04:01 PM

Price Summary

Today's High

₹ 36.5

Today's Low

₹ 34.9

52 Week High

₹ 45.99

52 Week Low

₹ 28.21

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

15.98 Cr.

Enterprise Value

21.7 Cr.

No. of Shares

0.44 Cr.

P/E

0

P/B

1.22

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  29.42

CASH

0.06 Cr.

DEBT

5.78 Cr.

Promoter Holding

51.49 %

EPS (TTM)

₹  -2.07

Sales Growth

-14.93%

ROE

-7.79 %

ROCE

-3.03%

Profit Growth

24.62 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-14.93%
3 Year-21.98%
5 Year-0.03%

Profit Growth

1 Year24.62%
3 Year-181.73%
5 Year-201.58%

ROE%

1 Year-7.79%
3 Year-4.28%
5 Year2.02%

ROCE %

1 Year-3.03%
3 Year-0.04%
5 Year6.01%

Debt/Equity

0.4567

Price to Cash Flow

5.95

Interest Cover Ratio

-0.8085

CFO/PAT (5 Yr. Avg.)

3.68663145062983

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 51.49 0.00
Jun 2025 51.49 0.00
Mar 2025 51.49 0.00
Dec 2024 51.49 0.00
Sep 2024 51.49 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 3.4395 Cr.
  • The company has an efficient Cash Conversion Cycle of 82.4399 days.
  • The company has a high promoter holding of 51.49%.

 Limitations

  • The company has shown a poor profit growth of -181.73015095686% for the Past 3 years.
  • The company has shown a poor revenue growth of -21.9833303183619% for the Past 3 years.
  • Company has a poor ROE of -4.27993333333333% over the past 3 years.
  • Company has a poor ROCE of -0.0402666666666667% over the past 3 years
  • Company has low Interest coverage ratio of -0.8085.
  • The company has a low EBITDA margin of 3.75973094075134% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 61.6463.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 8.85 4.8 5.34 6.45 7.82
Total Expenditure 8.3 5.1 5.23 6.67 7.17
Operating Profit 0.54 -0.3 0.11 -0.22 0.64
Other Income 0.27 0.36 -0.56 0.12 0.21
Interest 0.22 0.21 0.21 0.14 0.1
Depreciation 0.24 0.24 0.24 0.24 0.24
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.36 -0.39 -0.89 -0.48 0.51
Tax 0.06 -0.08 -0.22 -0.13 0.11
Profit After Tax 0.3 -0.31 -0.67 -0.35 0.4
Adjusted EPS (Rs) 0.67 -0.69 -1.5 -0.79 0.9

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 34.81 53.56 38.76 29.9 25.43
Total Expenditure 31.85 50.36 36.45 30.55 25.3
Operating Profit 2.97 3.2 2.31 -0.65 0.13
Other Income 0.03 0.8 0.26 0.64 0.19
Interest 0.44 0.45 0.76 0.87 0.78
Depreciation 0.87 0.93 0.92 1.03 0.94
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.68 2.62 0.89 -1.92 -1.4
Tax 0.59 0.74 0.23 -0.55 -0.38
Net Profit 1.08 1.88 0.65 -1.36 -1.03
Adjusted EPS (Rs.) 2.44 4.24 1.47 -3.07 -2.31

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 4.44 4.44 4.44 4.44 4.44
Total Reserves 8.12 10.03 10.6 9.27 8.22
Borrowings 3.16 2.9 1.98 1.06 0.42
Other N/C liabilities 1.04 0.98 0.92 0.18 -0.07
Current liabilities 9.28 10.61 14.51 11.01 10.05
Total Liabilities 26.04 28.96 32.46 25.95 23.06
Assets
Net Block 8.71 8.79 9 9.94 9.28
Capital WIP 0 0.21 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.03 4.52 3.64 2.93 2.06
Loans & Advances 2.09 1.73 1.66 0.82 0.53
Other N/C Assets 0.07 0.15 0.61 0.73 0.04
Current Assets 15.14 13.57 17.55 11.53 11.16
Total Assets 26.04 28.96 32.46 25.95 23.06
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 1.68 2.62 0.89 -1.92 -1.4
Adjustment 1.46 0.96 2.25 1.37 1.53
Changes in Assets & Liabilities 2.18 -4.16 -4.43 0.89 2.53
Tax Paid -0.48 -0.67 -0.41 -0.37 0.03
Operating Cash Flow 4.84 -1.26 -1.71 -0.03 2.69
Investing Cash Flow -2.16 -4.97 -0.08 0.41 1.53
Financing Cash Flow -0.33 2.27 1.61 -0.41 -4.21
Net Cash Flow 2.35 -3.95 -0.17 -0.03 0

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 51.49 51.49 51.49 51.49 51.49
maya satish thakur 15.55 15.55 15.55 15.55 15.55
rishikesh satishbhai thak... 18.95 18.95 18.95 18.95 18.95
satish ganpatrao thakur 14.91 14.91 14.91 14.91 14.91
shriniwas vasantrao thaku... 2.09 2.09 2.09 2.09 2.09
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 48.51 48.51 48.51 48.51 48.51
chirayu jayesh shah (huf)... 1.74 1.27 1.09 1.07 1.19
daksha vishanji kotak 1.87 1.87 1.87 1.87 1.87
gurudev marketing pvt. lt... 5.76 5.76 5.76 - 5.76
llp 0.01 0.01 0.01 0.01 0.01
thakorbhai vinubhai mistr... - 1.08 - - 1.00
gurudev marketing pvt. lt... - - - 5.76 -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Link Pharma Chem - Quaterly Results 1 Aug, 1:52 PM Link Pharma Chem - Quaterly Results 1 Aug, 1:52 PM Link Pharma Chem - Quaterly Results 1 Aug, 1:52 PM Link Pharma Chem - Quaterly Results 27 May, 6:25 PM Link Pharma Chem - Quaterly Results 27 May, 6:25 PM Link Pharma Chem - Quaterly Results 7 Feb, 5:24 PM Link Pharma Chem - Quaterly Results 7 Feb, 5:24 PM Link Pharma Chem - Quaterly Results 7 Feb, 5:24 PM Link Pharma Chem informs about board meeting 28 Jan, 5:07 PM Link Pharma Chem - Quaterly Results 11 Nov, 2:11 PM Link Pharma Chem - Quaterly Results 11 Nov, 2:11 PM Link Pharma Chem - Quaterly Results 11 Nov, 2:11 PM Link Pharma Chem informs about board meeting 30 Oct, 2:38 PM Link Pharma Chem informs about disclosure 7 Oct, 12:34 PM Link Pharma Chem informs about closure of trading window 24 Sep, 3:00 PM Link Pharma Chem - Quaterly Results 9 Aug, 1:47 PM Link Pharma Chem - Quaterly Results 9 Aug, 1:47 PM Link Pharma Chem - Quaterly Results 9 Aug, 1:47 PM Link Pharma Chem informs about confirmation certificate 5 Jul, 2:24 PM Link Pharma Chem informs about issuance of letter of confirmation 23 Apr, 4:52 PM Link Pharma Chem informs about details of loss of certificate 1 Apr, 5:13 PM Link Pharma Chem informs about closure of trading window 27 Mar, 4:44 PM Link Pharma Chem informs about sale of unutilized office located at Vadodara 14 Mar, 4:34 PM Link Pharma Chem informs about newspaper advertisements 12 Feb, 1:30 PM Link Pharma Chem - Quaterly Results 9 Feb, 2:58 PM Link Pharma Chem - Quaterly Results 9 Feb, 2:58 PM Link Pharma Chem - Quaterly Results 9 Feb, 2:58 PM Link Pharma Chem informs about loss of share certificates 29 Jan, 5:23 PM Link Pharma Chem informs about board meeting 31 Oct, 5:15 PM Link Pharma Chem informs about loss of share certificate(s) 20 Oct, 1:07 PM Link Pharma Chem informs about details of loss of certificate 23 Sep, 11:44 AM Link Pharma Chem informs about unaudited financial results 14 Aug, 4:25 PM Link Pharma Chem - Quaterly Results 14 Aug, 3:06 PM Link Pharma Chem informs about details of loss of certificate 5 May, 1:01 PM Link Pharma Chem informs about issuance of letter of confirmation 17 Apr, 11:55 AM Link Pharma Chem - Quaterly Results 9 Feb, 2:43 PM Link Pharma Chem - Quaterly Results 9 Feb, 2:43 PM Link Pharma Chem - Quaterly Results 9 Feb, 2:43 PM Link Pharma Chem informs about closure of trading window 27 Sep, 4:31 PM Link Pharma Chem informs about resignation of CS cum CO 16 Sep, 4:26 PM Link Pharma Chem informs about loss of share certificate 16 Jul, 11:58 AM Link Pharma Chem informs about newspaper advertisements 14 Jul, 1:01 PM Link Pharma Chem informs about newspaper publications 31 May, 1:08 PM Link Pharma Chem informs about non- applicability of large corporate entity 11 May, 1:00 PM Link Pharma Chem informs about compliance certificate 8 Apr, 4:55 PM Link Pharma Chem informs about disclosure 2 Apr, 11:42 AM Link Pharma Chem informs about closure of trading window 24 Mar, 11:36 AM Link Pharma Chem informs about certificate 6 Oct, 3:39 PM Link Pharma Chem informs about compliance certificate 3 Jul, 2:06 PM Link Pharma Chem informs about closure of trading window 26 Jun, 3:57 PM

Link Pharma Chem Stock Price Analysis and Quick Research Report. Is Link Pharma Chem an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Link Pharma Chem. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Link Pharma Chem has a PE ratio of -17.3521045272648 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Link Pharma Chem has ROA of -4.1921% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Link Pharma Chem has a Current ratio of 1.1102.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Link Pharma Chem has a ROE of -7.7912%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Link Pharma Chem has a Debt to Equity ratio of 0.4567 which means that the company has low proportion of debt in its capital.

  • Sales growth: Link Pharma Chem has reported revenue growth of -14.9319% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Link Pharma Chem for the current financial year is 0.508779793499888%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Link Pharma Chem is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Link Pharma Chem is Rs -2.0741. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Link Pharma Chem in Ticker for free. Also, one can get the intrinsic value of Link Pharma Chem by using Valuation Calculators, which are available with a Finology ONE subscription. 

Link Pharma Chem FAQs

Q1. What is Link Pharma Chem share price today?
Ans: The current share price of Link Pharma Chem is Rs 35.99.

Q2. What is the market capitalisation of Link Pharma Chem?
Ans: Link Pharma Chem has a market capitalisation of Rs 15.981604232 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Link Pharma Chem?
Ans: The PE ratio of Link Pharma Chem is -17.3521045272648 and the P/B ratio of Link Pharma Chem is 1.22341727401284, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Link Pharma Chem share?
Ans: The 52-week high share price of Link Pharma Chem is Rs 45.99, and the 52-week low share price of Link Pharma Chem is Rs 28.21.

Q5. Does Link Pharma Chem pay dividends?
Ans: Currently, Link Pharma Chem does not pay dividends. Dividend yield of Link Pharma Chem is around 0%.

Q6. What are the face value and book value of Link Pharma Chem shares?
Ans: The face value of Link Pharma Chem shares is Rs 10, while the book value per share of Link Pharma Chem is around Rs 29.4176. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Link Pharma Chem?
Ans: Link Pharma Chem has a total debt of Rs 5.7824 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Link Pharma Chem?
Ans: The ROE of Link Pharma Chem is -7.7912% and ROCE of Link Pharma Chem is -3.0308%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Link Pharma Chem a good buy for the long term?
Ans: The Link Pharma Chem long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Link Pharma Chem undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Link Pharma Chem appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Link Pharma Chem’s financials?
Ans: You can review Link Pharma Chem’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Link Pharma Chem
X